SThree (STEM) Share Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for SThree in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" STEM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in STEM, but not buy additional shares or sell existing shares.
View STEM analyst ratings or view top-rated stocks.

1 brokers have issued 1-year price targets for SThree's shares. Their STEM share price forecasts range from GBX 450 to GBX 450. On average, they predict the company's stock price to reach GBX 450 in the next year. This suggests a possible upside of 23.8% from the stock's current price.
View analysts price targets for STEM or view top-rated stocks among Wall Street analysts.

SThree's stock was trading at GBX 403 at the start of the year. Since then, STEM stock has decreased by 9.8% and is now trading at GBX 363.50.
View the best growth stocks for 2023 here.

SThree announced a dividend on Tuesday, July 25th. Investors of record on Thursday, November 9th will be paid a dividend of GBX 5 per share on Friday, December 8th. This represents a yield of 1.43%. The ex-dividend date of this dividend is Thursday, November 9th. The official announcement can be viewed at this link.
Read our dividend analysis for STEM.

SThree (LON:STEM) pays an annual dividend of GBX 16 per share and currently has a dividend yield of 4.45%. STEM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 4,324.32%. Payout ratios above 75% are not desirable because they may not be sustainable.
Read our dividend analysis for STEM.

Based on aggregate information from My MarketBeat watchlists, some companies that other SThree investors own include Dynavax Technologies (DVAX), Aldeyra Therapeutics (ALDX), Ares Capital (ARCC), BAE Systems (BA), BioCryst Pharmaceuticals (BCRX), BioNTech (BNTX), Centamin (CEY), Countryside Partnerships (CSP) and Enbridge (ENB).

SThree trades on the London Stock Exchange (LON) under the ticker symbol "STEM."

Shares of STEM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

One share of STEM stock can currently be purchased for approximately GBX 363.50.

SThree (LON:STEM) has a market capitalization of £488.98 million and generates £1.69 billion in revenue each year. The company earns £49.90 million in net income (profit) each year or GBX 0.37 on an earnings per share basis.

The company employs 2,800 workers across the globe.

SThree's mailing address is 75 King William Street, 1st Floor, London EC4N 7BE, United Kingdom. The official website for the company is www.sthree.com. The company can be reached via phone at 44 20 7268 6000.